Cargando…
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
Approximately one-half of the phenotypic susceptibility to atherosclerotic cardiovascular disease (ASCVD) has a genetic basis. Although individual allelic variants generally impart a small effect on risk for ASCVD, an emerging body of data has shown that the aggregation and weighting of many of thes...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627888/ https://www.ncbi.nlm.nih.gov/pubmed/36341217 http://dx.doi.org/10.1016/j.jacasi.2021.08.008 |
_version_ | 1784823073707393024 |
---|---|
author | Tada, Hayato Yeo, Khung Keong Li, Jian-Jun Tan, Kathryn Ako, Junya Krittayaphong, Rungroj San Tan, Ru Aylward, Philip E. Lam, Carolyn S.P. Baek, Sang Hong Dalal, Jamshed Fong, Alan Li, Yi-Heng O’Brien, Richard C. Natalie Koh, Si Ya Scherer, Daniel J. Kang, Vernon Nelson, Adam J. Butters, Julie Nicholls, Stephen J. |
author_facet | Tada, Hayato Yeo, Khung Keong Li, Jian-Jun Tan, Kathryn Ako, Junya Krittayaphong, Rungroj San Tan, Ru Aylward, Philip E. Lam, Carolyn S.P. Baek, Sang Hong Dalal, Jamshed Fong, Alan Li, Yi-Heng O’Brien, Richard C. Natalie Koh, Si Ya Scherer, Daniel J. Kang, Vernon Nelson, Adam J. Butters, Julie Nicholls, Stephen J. |
author_sort | Tada, Hayato |
collection | PubMed |
description | Approximately one-half of the phenotypic susceptibility to atherosclerotic cardiovascular disease (ASCVD) has a genetic basis. Although individual allelic variants generally impart a small effect on risk for ASCVD, an emerging body of data has shown that the aggregation and weighting of many of these genetic variations into “scores” can further discriminate an individual’s risk beyond traditional risk factors alone. Consistent with the theory of population genetics, such polygenic risk scores (PRS) appear to be ethnicity specific because their elements comprise single-nucleotide variants that are always ethnicity specific. The currently available PRS are derived predominantly from European ancestry and thus predictably perform less well among non-European participants, a fact that has implications for their use in the Asia-Pacific region. This paper describes the current state of knowledge of PRS, the available data that support their use in this region, and highlights the needs moving forward to safely and effectively implement them in clinical care in the Asia-Pacific region. |
format | Online Article Text |
id | pubmed-9627888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96278882022-11-04 Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region Tada, Hayato Yeo, Khung Keong Li, Jian-Jun Tan, Kathryn Ako, Junya Krittayaphong, Rungroj San Tan, Ru Aylward, Philip E. Lam, Carolyn S.P. Baek, Sang Hong Dalal, Jamshed Fong, Alan Li, Yi-Heng O’Brien, Richard C. Natalie Koh, Si Ya Scherer, Daniel J. Kang, Vernon Nelson, Adam J. Butters, Julie Nicholls, Stephen J. JACC Asia State-of-the-Art Review Approximately one-half of the phenotypic susceptibility to atherosclerotic cardiovascular disease (ASCVD) has a genetic basis. Although individual allelic variants generally impart a small effect on risk for ASCVD, an emerging body of data has shown that the aggregation and weighting of many of these genetic variations into “scores” can further discriminate an individual’s risk beyond traditional risk factors alone. Consistent with the theory of population genetics, such polygenic risk scores (PRS) appear to be ethnicity specific because their elements comprise single-nucleotide variants that are always ethnicity specific. The currently available PRS are derived predominantly from European ancestry and thus predictably perform less well among non-European participants, a fact that has implications for their use in the Asia-Pacific region. This paper describes the current state of knowledge of PRS, the available data that support their use in this region, and highlights the needs moving forward to safely and effectively implement them in clinical care in the Asia-Pacific region. Elsevier 2021-12-21 /pmc/articles/PMC9627888/ /pubmed/36341217 http://dx.doi.org/10.1016/j.jacasi.2021.08.008 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | State-of-the-Art Review Tada, Hayato Yeo, Khung Keong Li, Jian-Jun Tan, Kathryn Ako, Junya Krittayaphong, Rungroj San Tan, Ru Aylward, Philip E. Lam, Carolyn S.P. Baek, Sang Hong Dalal, Jamshed Fong, Alan Li, Yi-Heng O’Brien, Richard C. Natalie Koh, Si Ya Scherer, Daniel J. Kang, Vernon Nelson, Adam J. Butters, Julie Nicholls, Stephen J. Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region |
title | Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region |
title_full | Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region |
title_fullStr | Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region |
title_full_unstemmed | Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region |
title_short | Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region |
title_sort | polygenic risk scores for atherosclerotic cardiovascular disease in the asia-pacific region |
topic | State-of-the-Art Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627888/ https://www.ncbi.nlm.nih.gov/pubmed/36341217 http://dx.doi.org/10.1016/j.jacasi.2021.08.008 |
work_keys_str_mv | AT tadahayato polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT yeokhungkeong polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT lijianjun polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT tankathryn polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT akojunya polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT krittayaphongrungroj polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT santanru polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT aylwardphilipe polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT lamcarolynsp polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT baeksanghong polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT dalaljamshed polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT fongalan polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT liyiheng polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT obrienrichardc polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT nataliekohsiya polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT schererdanielj polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT kangvernon polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT nelsonadamj polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT buttersjulie polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion AT nichollsstephenj polygenicriskscoresforatheroscleroticcardiovasculardiseaseintheasiapacificregion |